Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspira Women's Health Inc.AWH · Entity 7871 | Director | March 19, 2021 | March 23, 2021 |
| Privia Health Group, Inc.PRVA · Entity 1532 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspira Women's Health Inc.
Report date March 19, 2021 · Filed March 23, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 128,632 |
Reported balance
After 2021-03-19 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-03-19 · Grant · Acquired 15,680 · Balance 128,632 F1: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021. F2: Total reflects the adjustment of 16,554 shares of common stock previously reported as part of a restricted stock unit grant made on March 19, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021.
F2: Total reflects the adjustment of 16,554 shares of common stock previously reported as part of a restricted stock unit grant made on March 19, 2020.
Privia Health Group, Inc.
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | Direct | 42,814 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 8,463 · Balance 42,814 F1: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2026 Filed May 22, 2026 12:26 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 8,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-26-000042 · wk-form4_1779452765.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,814 F1 · shares: On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:02 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 8,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-25-000074 · wk-form4_1748034128.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,351 F1 · shares: On May 21, 2025, the reporting person received 8,396 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| May 22, 2024 Filed May 23, 2024 21:02 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 11,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-24-000086 · wk-form4_1716498115.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,955 F1 · shares: On May 22, 2024, the reporting person received 11,124 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2025 annual meeting of stockholders and (ii) the first anniversary of the date of the grant. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:30 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 7,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-23-000153 · wk-form4_1688589018.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,831 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 12:49 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 7,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000048 · wf-form4_164916296106704.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,073 F1 · security: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the first anniversary of the grant date. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 21:39 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 15,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001232953-21-000001 · primary_doc.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,632 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021. F2 · balance_after: Total reflects the adjustment of 16,554 shares of common stock previously reported as part of a restricted stock unit grant made on March 19, 2020. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:53 UTC Amendment | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 115,148 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001232953-20-000002 · primary_doc.xml · derivative · entry 2 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,148 Underlying: Common Stock · 115,148 shares Expires 2030-03-19 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2020, June 1, 2020, September 1, 2020 and December 1, 2020. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:53 UTC Amendment | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 66,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001232953-20-000002 · primary_doc.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,506 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2020, June 1, 2020, September 1, 2020 and December 1, 2020. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:03 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 115,148 | $0.68 Strike: $0.68 | $78,300.64 |
DisclosureSEC source: 0001232953-20-000001 · primary_doc.xml · derivative · entry 2 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,148 Underlying: Common Stock · 115,148 shares Expires 2030-03-19 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2020, June 1, 2020, September 1, 2020 and December 1, 2020. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:03 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 66,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001232953-20-000001 · primary_doc.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,506 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2020, June 1, 2020, September 1, 2020 and December 1, 2020. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 23:31 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 92,942 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001232953-19-000001 · primary_doc.xml · derivative · entry 2 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,942 Underlying: Common Stock · 92,942 shares Expires 2029-03-26 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 23:31 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 35,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001232953-19-000001 · primary_doc.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,288 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 21:53 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 27,871 | $0.00 | $0.00 |
DisclosureSEC source: 0001232953-18-000003 · primary_doc.xml · nonDerivative · entry 1 COCOZZA NANCY G · CIK 0001232953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,871 F1 · shares: The option vests 32% on September 1, 2018 and 68% on December 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.